CN103031328A - Improvement of expression quantity of foreign proteins by fusion label - Google Patents
Improvement of expression quantity of foreign proteins by fusion label Download PDFInfo
- Publication number
- CN103031328A CN103031328A CN2012104767920A CN201210476792A CN103031328A CN 103031328 A CN103031328 A CN 103031328A CN 2012104767920 A CN2012104767920 A CN 2012104767920A CN 201210476792 A CN201210476792 A CN 201210476792A CN 103031328 A CN103031328 A CN 103031328A
- Authority
- CN
- China
- Prior art keywords
- subtilis
- gfp
- plasmid
- hag
- fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the field of molecular biology, and relates to application of previous 50 amino acids of Bacillus subtilis l68 flagellin Hag, and a novel method for improving the expression quantity of foreign proteins in Bacillus subtilis, and in particular relates to a method for improving the expression quantity of foreign proteins by way of fusion expression. A fusion label Hag 50 coding sequence is fused and recombined with that of the foreign proteins to construct a recombinant plasmid in fusion expression and convert the Bacillus subtilis. The obtained recombinant bacteria have already improved the expression quantity of foreign proteins successfully.
Description
Technical field
The present invention relates to a kind of novel method that in subtilis, improves the exogenous protein expression amount.Front 50 amino acid (Hag50) that more specifically relate to subtilis flagellin Hag are realized the overexpression of exogenous protein as fusion tag.
Background technology
Intestinal bacteria are the first-selected expression systems of expressing foreign protein always. but since foreign protein in the expression process easily by the host cell proteins enzyme liberating or form inclusion body, and intestinal bacteria have the thermal source lipopolysaccharides like that, its application is restricted. because the genetic background of subtilis (Bacillus subtilis) is clear, and be a kind of food-grade microorganisms, so subtilis is developed rapid as the host of exogenous gene expression and shows good prospects for commercial application in recent years.Although mainly utilize subtilis to realize the secreting, expressing of exogenous protein, the example of successful intracellular expression also a lot (Zweers JC, Barak I in subtilis, Dorte B, et al.Micro Cell Fact, 2008,7:10).Egfp (Green Fluorescent Protein, GFP) is widely used in reporter protein, merges the fields such as mark, protein positioning.GFP has been applied to all respects of biotechnology widely as a kind of novel detection by quantitative means.
The protein expression amount is the emphasis that researcher is concerned about always.By optimizing promotor and ribosome bind site, the coexpression molecular chaperones reduces the proteolytic enzyme expression amount, and the means such as codon of Optimized Coding Based gene can significantly improve the expression amount of exogenous protein.But for some exogenous protein, although by above optimization expression the amount still very low or requirement that do not reach suitability for industrialized production.So, find that the new method that can improve the exogenous protein expression amount is particularly important.The present invention is take GFP as reporter protein matter, merges the expression amount that the Hag label attempts improving GFP by the N end.
Summary of the invention
Purpose of the present invention improves the expression amount of reporter protein matter GFP by fusion molecule label H ag50 (front 50 amino acid of Hag).
The technical solution adopted in the present invention is:
The present invention relates to front 50 amino acid (Hag50) of flagellin Hag, be built into recombinant plasmid pMA5-Hag50-GFP after the encoding sequence of the encoding gene of this fragment and external source target protein gene merged, the encoding gene and the external source target protein gene (GFP) that contain strong promoter HpaII, Hag50 in this plasmid, it can be in subtilis expressed fusion protein.
The recombinant bacterial strain that obtains behind the recombinant plasmid transformed subtilis of the amalgamation and expression recombinant protein of the structure that the present invention relates to, the expression external source target protein GFP of composing type, it is strong and weak to detect the fluorescence of recombinant protein GFP by fluorescence spectrophotometer.Blank among the present invention is that the GFP gene is directly connected on the plasmid pMA5, consists of recombinant plasmid pMA5-GFP.The F-7000 of Hitachi type fluorescence spectrophotometer is adopted in fluoroscopic examination, and the excitation wavelength during detection is 488nm, and emission wavelength is 547nm.Fluorescence is strong and weak with " relative intensity of fluorescence unit " expression.
The present invention relates to the primer sequence of front 50 amino acid coding Hag50 amplification of flagellin Hag:
hag-F:AGTG
CATATGAGAATTA?ACCACA?ATATTGC
hag50-R:CTG
GAATTCTTCAGAGATCGCAAGACCTG
Compare with methods known in the art, the present invention utilizes front 50 amino acid of flagellin Hag to improve exogenous protein at intracellular expression level as fusion tag.Compared with the control, the GFP expression amount after the fusion has improved 12 times.
Description of drawings
Fig. 1 amalgamation and expression Hag50-GFP recombinant plasmid pMA5-Hag50-GFP makes up schema.Amp and bla represent ampicillin resistance gene, are used for the screening escherichia coli transformant, and the plasmid that is used for increasing is used.Hag50-GFP is front 50 amino acid encode fragments of flagellin Hag and the fusion fragment of green fluorescent protein GFP gene, and Promoter HpaII is composing type strong promoter HpaII; Ori is the intestinal bacteria replicon.
Fig. 2 contrasts recombinant plasmid pMA5-GFP and makes up synoptic diagram.Directly the GFP gene is connected to carrier pMA5 and upward consists of plasmid pMA5-GFP.
The relative intensity of fluorescence of GFP among Fig. 3 recombinant bacterial strain PG800 and the PHG800.Recombinant bacterial strain PG800 expresses the GFP protein that does not contain molecular label Hag50; Recombinant bacterial strain PHG800 is with the Hag50-GFP fused protein of molecular label Hag50.
Embodiment
1. the acquisition of front 50 amino acid coding of subtilis flagellin Hag
(the Genbank sequence number: M26948) total length is 915bp to the hag gene of B.subtilis 168, is one of protein of expression amount maximum in the subtilis.Cultured B.subtilis168 bacterium liquid is extracted genomic dna according to bacterial genomes rapid extraction test kit specification sheets.Hag gene order design PCR primer hag-F and hag50-R in the full genome of B.subtilis168 of delivering according to NCBI, introduce respectively NdeI and EcoRI restriction enzyme site in the upstream and downstream primer, primer is synthetic by Sangon Biotech (Shanghai) Co., Ltd..Take the genomic dna that extracts as template, front 50 amino acid coding of pcr amplification flagellin Hag, amplified production detects with agarose gel electrophoresis, and size conforms to expection.The polysaccharase of amplification usefulness is the KOD plus that (Shanghai) bio tech ltd spins in Japan.Primer sequence is as follows, and wherein the underscore representative is restriction enzyme site.
hag-F:AGTG
CATATGAGAATTAACCACAATATTGC
hag50-R:CTG
GAATTCTTCAGAGATCGCAAGACCTG
The PCR product that the clone obtains carries out product purification, and-20 ℃ save backup.
2. the amplification of egfp gene gfp
Gfp gene (the Genbank sequence number: U55762) sequences Design PCR primer of delivering according to NCBI.Utilize primer GFP-f and GFP-R, take plasmid pEGFP as template, amplify the gfp gene of EcoRI and BamHI restriction enzyme site.Take GFP-F and GFP-R as primer, take plasmid pEGFP as template, amplify the gfp gene of NdeI and BamHI restriction enzyme site.The polysaccharase of amplification usefulness is the KOD plus that (Shanghai) bio tech ltd spins in Japan.Detect through nucleic acid electrophoresis, size conforms to expection.Further product purification also-20 ℃ saves backup.
GFP-F:GGCG
CATATGAGCAAGGGCGAGGAGCTGTTC
GFP-f:CCG
GAATTCAGCAAGGGCGAGGAGCTGTTC
GFP-R:GGC
GGATCCCTTGTACAGCTCGTCCATGCCGA
3. the structure of plasmid pMA5-Hag50-GFP
Making up flow process such as Fig. 1, at first is that the gfp gene that utilizes KOD plus (flat terminal) to amplify with EcoRI and BamHI restriction enzyme site is connected to the pUCX05 that cuts through the EcoRV enzyme, consists of plasmid pUCX-GFP.By adopting NdeI and EcoRI double digestion PCR product Hag50, reclaim rear clone in the plasmid of the pUCX-GFP that cuts through same enzyme through glue, obtain plasmid pUCX-Hag50-GFP.With NdeI and BamHI digested plasmid pUCX-Hag50-GFP, and glue recovery Hag50-GFP fragment, be connected in the pMA5 plasmid that same enzyme is cut, obtain recombinant plasmid pMA5-Hag50-GFP.
4. the structure of recombinant plasmid pMA5-GFP
Adopt NdeI and BamHI double digestion take the PCR product gfp that GFP-F and GFP-R go out as primer amplification, reclaim rear clone in the corresponding site of pMA5 through glue, obtain integrated recombinant plasmid pMA5-GFP (such as Fig. 2).
5. the Screening and Identification of recombinant plasmid transformed subtilis and transformant
Adopt electric shocking method that recombinant plasmid pMA5-Hag50-GFP and pMA5-GFP are transformed respectively (2.0kv in the subtilis WB800 bacterial strain, 1mm shocks by electricity time constant=4.5~5.0ms 1 time, Gene Pulser Xcell), coating contains the LB flat board of kantlex.After the incubated overnight, picking list bacterium colony point is seeded to 5mL and contains the LB liquid nutrient medium that final concentration is 50 μ g/mL kantlex from the flat board.Collect thalline and extract genomic dna according to bacterial genomes rapid extraction test kit specification sheets, whether transform successfully by PCR checking recombinant plasmid.Be accredited as and contain pMA5-Hag50-GFP bacterial strain called after PHG800, contain the bacterial strain called after PG800 of pMA5-GFP.
6. the detection of GFP in the subtilis recombinant bacterial strain
Recombinant bacterial strain PHG800 and PG800 are inoculated in respectively in the LB liquid nutrient medium of 5ml, cultivate 12h for 37 ℃.The centrifugal 15min of 10000rpm collects thalline, then with PBS washing three times, and is resuspended in the resuspended thalline of isopyknic PBS.Then add the N,O-Diacetylmuramidase that final concentration is 5mg/mL, 37 ℃ of water bath heat preservation 1h utilize ultrasonic disruption thalline (2min, 300W, Sonic, VCX500).Then utilize the F-7000 of Hitachi type fluorescence spectrophotometer to detect the power of fluorescence in the broken liquid, the excitation wavelength during detection is 488nm, and emission wavelength is 547nm.
The present invention relates to a kind of novel method that in subtilis, improves the exogenous protein expression amount.When realizing exogenous protein GFP with front 50 amino acid (Hag50) of subtilis flagellin Hag as fusion tag, can mention raising GFP expression amount and reach 12 times.Its discovery is for realizing that the overexpression of exogenous protein in subtilis provides possibility.
Claims (5)
1. utilize front 50 amino acid of flagellin Hag to improve the expression amount of exogenous protein in subtilis as fusion tag.
2. application as claimed in claim 1, it is characterized in that, utilize front 50 amino acid of bacillus subtilis spore flagellin Hag as fusion tag, with external source target protein gene fusion, vector construction hexose transport protein, and transform subtilis and obtain the subtilis recombinant bacterium, recombinant bacterial strain can effectively improve the expression level of exogenous protein.
3. application as claimed in claim 2 is characterized in that, external source target protein gene has bioactive albumen or enzyme for coding.
4. application as claimed in claim 3, it is characterized in that, described recombinant plasmid is the plasmid that subtilis flagellin encoding sequence and external source target protein gene fusion are obtained, the encoding gene that contains resistance selective marker gene, composing type strong promoter HpaII and the external source target protein matter of front 50 amino acid encode fragments, penbritin and the kantlex of Hag in the recombinant plasmid, the Plasmid Transformation subtilis of structure.
5. application as claimed in claim 4 is characterized in that, described recombined bacillus subtilis is with the sequestered plasmid, and the expression amount of exogenous protein that contains the recombinant bacterial strain of fusion tag obviously improves.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210476792.0A CN103031328B (en) | 2012-11-22 | 2012-11-22 | A kind of fusion tag is utilized to improve the expression amount of exogenous protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210476792.0A CN103031328B (en) | 2012-11-22 | 2012-11-22 | A kind of fusion tag is utilized to improve the expression amount of exogenous protein |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103031328A true CN103031328A (en) | 2013-04-10 |
CN103031328B CN103031328B (en) | 2015-08-05 |
Family
ID=48018728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210476792.0A Expired - Fee Related CN103031328B (en) | 2012-11-22 | 2012-11-22 | A kind of fusion tag is utilized to improve the expression amount of exogenous protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103031328B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108220322A (en) * | 2018-01-30 | 2018-06-29 | 江南大学 | A kind of DNA for improving subtilisin expression quantity |
CN111132996A (en) * | 2017-07-28 | 2020-05-08 | 普林斯顿大学理事会 | Fusion tag for recombinant protein expression |
CN115114934A (en) * | 2022-07-15 | 2022-09-27 | 广东工业大学 | Joint extraction method for label fusion |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801536A (en) * | 1985-10-11 | 1989-01-31 | Genetics Institute, Inc. | Method for producing heterologous proteins |
CN101128480A (en) * | 2004-12-02 | 2008-02-20 | Csir公司 | Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid |
CN101970469A (en) * | 2008-01-08 | 2011-02-09 | Csir公司 | Production of heterologous proteins or peptides |
-
2012
- 2012-11-22 CN CN201210476792.0A patent/CN103031328B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801536A (en) * | 1985-10-11 | 1989-01-31 | Genetics Institute, Inc. | Method for producing heterologous proteins |
CN101128480A (en) * | 2004-12-02 | 2008-02-20 | Csir公司 | Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid |
CN101970469A (en) * | 2008-01-08 | 2011-02-09 | Csir公司 | Production of heterologous proteins or peptides |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111132996A (en) * | 2017-07-28 | 2020-05-08 | 普林斯顿大学理事会 | Fusion tag for recombinant protein expression |
CN108220322A (en) * | 2018-01-30 | 2018-06-29 | 江南大学 | A kind of DNA for improving subtilisin expression quantity |
CN108220322B (en) * | 2018-01-30 | 2020-09-04 | 江南大学 | DNA for improving expression quantity of bacillus subtilis protein |
CN115114934A (en) * | 2022-07-15 | 2022-09-27 | 广东工业大学 | Joint extraction method for label fusion |
Also Published As
Publication number | Publication date |
---|---|
CN103031328B (en) | 2015-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Highly efficient expression of rabbit neutrophil peptide-1 gene in Chlorella ellipsoidea cells | |
CN105400784B (en) | A kind of bacillus subtilis inductivity strong promoter and its application | |
WO2012037774A1 (en) | Yeast strains for high-efficiency multi-copy expression of recombinant plectasin | |
CN102181469A (en) | Recombinant spore for displaying human serum albumin on surface of bacillus subtilis and preparation method thereof | |
CN103031328B (en) | A kind of fusion tag is utilized to improve the expression amount of exogenous protein | |
WO2018045855A1 (en) | Method for using single-stranded ribonucleic acid to convert penicillium amagasakiense spores and manufacture protein | |
CA1202258A (en) | Expression vector carrying a gene coding for a phosphate-binding protein, a method for preparing the same and a method for producing a polypeptide using the same | |
CN107119058A (en) | A kind of MS2 capsid proteins fusion expression method and its application | |
CN105018407A (en) | Bacillus subtilis of secretory expression proline aminopeptidase and application thereof | |
CN102925475B (en) | Novel method for realizing secreting expression of exogenous protein by using novel transfer signal | |
CN114672449A (en) | Strain for efficiently expressing lactoferrin by using temperature-sensitive promoter as well as construction method and application of strain | |
CN110951760B (en) | Protein time-delay expression switch and application thereof in production of glucaric acid | |
CN103695457B (en) | A kind of preparation method of recombinant porcine alpha interferon | |
CN105671069B (en) | A kind of bee peptide expression vector and its construction method and application | |
CN103667291B (en) | Derive from endosperm specificity expression promoter and the application thereof of paddy rice | |
CN102344900A (en) | Engineering bacterium for expressing antihypertensive peptide and method for preparing antihypertensive peptide | |
CN106367430A (en) | Efficient gene knockout vector construction method and constructed engineering bacteria | |
CN103993030A (en) | Method of shearing fusion protein by escherichia coli intracellular protease | |
CN104513830A (en) | Gene expression vector applicable to gluconobacter oxydans and application of gene expression vector | |
WO2009038841A3 (en) | Portable, temperature and chemically inducible expression vector for high cell density expression of heterologous genes in escherichia coli | |
CN1163610C (en) | Carrier effectively expressed in plant | |
CN104140976B (en) | Construction method for the linear SUMO carrier of homologous recombination | |
WO2024077445A1 (en) | 5'utr element and use thereof in production of l-arginine | |
CN103194483A (en) | Method for preparing active small peptide by establishing oligopeptide concatemer yeast expression plasmid | |
CN108486115A (en) | A kind of transfection method and its application for the expression of crayfish Cells Exogenous genetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150805 Termination date: 20151122 |
|
CF01 | Termination of patent right due to non-payment of annual fee |